Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[5] [6] Early-phase clinical trials including a Phase 2 trial published in the New England Journal of Medicine (2023) have reported significant reductions in body weight and improvements in metabolic markers, though this evidence remains preliminary and is not sufficient to establish a clinical dosing or reconstitution standard
Specifically, while obesity surgery and LIRA/PYY 3-36 co-administration resulted in comparable changes in body weight in obese rats, only surgery resulted in profound changes to the hypothalamic transcriptome
The implications for long-term metabolic health deserve consideration
Guan, H
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your predisposition in key GLP-1 and GIP receptor pathwaysspecifically variants in GIPR (rs1800437)that can inform discussions with your provider about expected response patterns and whether personalized dosing or formulation choices might optimize your outcome
The blood alcohol level chart is an estimate only
